Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade D 281.42 1.05% 2.92
ABMD closed up 1.05 percent on Friday, October 23, 2020, on 70 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Oct 29
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical ABMD trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Crossed Above 20 DMA Bullish 1.05%
Pocket Pivot Bullish Swing Setup 1.05%
NR7 Range Contraction 1.05%
Inside Day Range Contraction 1.05%
Fell Below 20 DMA Bearish 3.24%
Down 3 Days in a Row Weakness 3.24%
50 DMA Resistance Bearish 1.40%
Upper Bollinger Band Walk Strength 1.40%
Older End-of-Day Gignals for ABMD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Medicine Catheter Prosthetics Circulatory System Interventional Cardiology Cardiology Heart Diseases Acute Heart Failure Heart Attack

Is ABMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 319.19
52 Week Low 119.0101
Average Volume 289,826
200-Day Moving Average 224.91
50-Day Moving Average 283.21
20-Day Moving Average 274.67
10-Day Moving Average 279.72
Average True Range 9.37
ADX 13.61
+DI 19.71
-DI 22.03
Chandelier Exit (Long, 3 ATRs ) 263.22
Chandelier Exit (Short, 3 ATRs ) 283.52
Upper Bollinger Band 288.07
Lower Bollinger Band 261.26
Percent B (%b) 0.75
BandWidth 9.76
MACD Line 0.56
MACD Signal Line -0.64
MACD Histogram 1.2034
Fundamentals Value
Market Cap 12.68 Billion
Num Shares 45 Million
EPS 3.47
Price-to-Earnings (P/E) Ratio 81.03
Price-to-Sales 15.94
Price-to-Book 11.39
PEG Ratio 2.75
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 289.85
Resistance 3 (R3) 289.10 285.55 288.45
Resistance 2 (R2) 285.55 283.40 285.92 287.98
Resistance 1 (R1) 283.48 282.07 284.52 284.23 287.51
Pivot Point 279.93 279.93 280.44 280.30 279.93
Support 1 (S1) 277.86 277.78 278.90 278.61 275.33
Support 2 (S2) 274.31 276.45 274.68 274.86
Support 3 (S3) 272.24 274.31 274.40
Support 4 (S4) 272.99